Stay updated on Pembrolizumab Combo in Gastro Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Gastro Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor update to the page history rather than substantive content changes.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision tag v3.5.4 has been added, replacing the previous v3.5.3 in the page's revision history. This indicates a software/maintenance update to the study page.SummaryDifference0.1%

- Check49 days agoChange DetectedClinicalTrials.gov’s page footer/update label changed from revision **v3.5.0** to **v3.5.3**, reflecting a site/version update without changing the study record content.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page shows revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check121 days agoChange DetectedThe update adds a related topic 'Gastric cancer' and an external resource link to the Genetic and Rare Diseases Information Center, plus a page revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Gastro Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.